Recent Progress in Thiazole, Thiosemicarbazone, and Semicarbazone Derivatives as Antiparasitic Agents Against Trypanosomatids and Plasmodium spp.
Molecules · 16.04.2025 · 30 (8) · 1788
DOI: 10.3390/molecules30081788 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 16.04.2025. Verfasst von Pamela Souza Tada da Cunha und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drugs and Medicines, School of Pharmaceutical Sciences, Sao Paulo State University (UNESP), Araraquara 14800-903, SP, Brazil. Hauptthemen laut MEDLINE: Thiosemicarbazones, Thiazoles, Antiparasitic Agents, Semicarbazones. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 184 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq).
Abstract (Originalsprache)
Neglected tropical diseases (NTDs), including Chagas disease, human African trypanosomiasis (HAT), leishmaniasis, and malaria, remain a major global health challenge, disproportionately affecting low-income populations. Current therapies for these diseases suffer from significant limitations, such as reduced efficacy, high toxicity, and emerging parasite resistance, highlighting the urgent need for new therapeutic strategies. In response, substantial efforts have been directed toward the synthesis of new molecules with improved potency, selectivity, and pharmacokinetic profiles. However, despite many of these compounds exhibiting favorable ADMET (absorption, distribution, metabolism, excretion, and toxicity) profiles and strong in vitro activity, their translation into in vivo models remains limited. Key challenges include the lack of investment, the absence of fully representative experimental models, and difficulties in extrapolating cell-based assay results to more complex biological systems. In this review, we analyzed the latest advancements (2019–2024) in the development of these compound classes, correlating predictive parameters with their observed biological activity. Among these parameters, we highlighted the partition coefficient (LogP), which measures a compound’s lipophilicity and influences its ability to cross biological membranes, and Caco-2 cell permeability, an in vitro model widely used to predict intestinal drug absorption. Additionally, we prioritized the most promising molecules and structural classes for pharmaceutical development, discussing structure–activity relationships (SARs) and the remaining challenges that must be overcome to enable the clinical application of these compounds in the treatment of NTDs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Drugs and Medicines, School of Pharmaceutical Sciences, Sao Paulo State University (UNESP), Araraquara 14800-903, SP, Brazil.
ORCID-Profile: Pamela Souza Tada da Cunha, Ana Luísa Rodriguez Gini, Chung Man Chin, Jean Leandro Dos Santos, Cauê Benito Scarim
Förderung
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
Zitieren
APA
Souza Tada da Cunha, P., Rodriguez Gini, A. L., Man Chin, C., Dos Santos, J. L., & Benito Scarim, C. (2025). Recent Progress in Thiazole, Thiosemicarbazone, and Semicarbazone Derivatives as Antiparasitic Agents Against Trypanosomatids and Plasmodium spp. Molecules, 30(8), 1788. https://doi.org/10.3390/molecules30081788
Vancouver
Souza Tada da Cunha P, Rodriguez Gini AL, Man Chin C, Dos Santos JL, Benito Scarim C. Recent Progress in Thiazole, Thiosemicarbazone, and Semicarbazone Derivatives as Antiparasitic Agents Against Trypanosomatids and Plasmodium spp. Molecules. 2025;30(8):1788. doi:10.3390/molecules30081788
BibTeX
@article{SouzaTadadaCunha2025,
author = {Souza Tada da Cunha, Pamela and Rodriguez Gini, Ana Luísa and Man Chin, Chung and Dos Santos, Jean Leandro and Benito Scarim, Cauê},
title = {Recent Progress in Thiazole, Thiosemicarbazone, and Semicarbazone Derivatives as Antiparasitic Agents Against Trypanosomatids and Plasmodium spp},
journal = {Molecules},
year = {2025},
volume = {30},
number = {8},
pages = {1788},
doi = {10.3390/molecules30081788}
}
EUVIMED